TrialCard takes closer aim at market access solutions

Pharmaceutical CommercePharmaceutical Commerce - May/June 2015

Leading copay-coupon provider expands its patient services with private equity help

TrialCard, Inc. (Cary, NC) has ridden the wave of growth in copay cards for patients for over a decade; now, with the boost from its partnership with the Denver, CO-based private equity firm, Excellere Partners, the company is looking to broaden its base of services to pharma marketers. Jointly, the two companies have just announced winning a “Deal of the Year” award from a local organization, the Association for Corporate Growth, Raleigh-Durham.

The partnership “will allow TrialCard to leverage valuable relationships in the healthcare space to drive organic growth as well as explore strategic acquisition opportunities that will further solidify its position as an industry leader,” according to a company statement. TrialCard has been experiencing “high growth,” according to a company representative, with its copay-management programs. And because such reimbursement services are critical to the success of specialty pharmaceutical commercialization, it is working with pharma clients on adherence, prescription abandonment, nursing support and related services, including analytics.

“TrialCard is in a unique position to build upon its history of leadership within the patient access and medication adherence market. We are focused on enhancing the value proposition that the company provides for customers through a combination of service optimization, organic growth initiatives, and complementary acquisitions that further improve patient outcomes and drive attractive return on investments to current and prospective customers,” added Brad Cornell, principal at Excellere.

Related Content
© 2024 MJH Life Sciences

All rights reserved.